Thromboembolic Events in Patients with HER2-Negative, Hormone Receptor-Positive, Metastatic Breast Cancer Treated with Ribociclib Combined with Letrozole or Fulvestrant: A Real-World Data.

Abdel-Razeq, Hikmat; Sharaf, Baha'; AlMasri, Rama; Abdel-Razeq, Rashid; Tamimi, Faris; Khader, Omar; Salama, Osama; Abunasser, Mahmoud; Edaily, Sarah; Abdulelah, Hazem

Abdel-Razeq, Hikmat; Sharaf, Baha'; AlMasri, Rama; Abdel-Razeq, Rashid; Tamimi, Faris; Khader, Omar; Salama, Osama; Abunasser, Mahmoud; Edaily, Sarah; Abdulelah, Hazem.

Afiliação

Abdel-Razeq H; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
Sharaf B; Department of Internal Medicine, School of Medicine, The University of Jordan, Amman, Jordan.
AlMasri R; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
Abdel-Razeq R; Department of Internal Medicine, Istishari Hospital, Amman, Jordan.
Tamimi F; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
Khader O; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
Salama O; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
Abunasser M; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
Edaily S; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
Abdulelah H; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.